Same-visit HIV testing in Trinidad and Tobago by Duke, Violet et al.
CORRESPONDENCE Open Access
Same-visit HIV testing in Trinidad and Tobago
Violet Duke
1, Sheila Samiel
2, David Musa
3, Cameile Ali
4, Catherine Chang-Kit
5, Cynthia Warner
6*
Abstract
Background: The Ministry of Health (hereafter, Ministry) of Trinidad and Tobago is responsible for delivery of all
health services in the country. The Ministry takes responsibility for direct delivery of care in the public sector and
has initiated a process whereby those seeking HIV test results could obtain confidential reports during a single-visit
to a testing location. The Ministry requested technical assistance with this process from the Caribbean
Epidemiology Centre (CAREC). The United States Centers for Disease Control and Prevention (CDC) played an
important role in this process through its partnership with CAREC.
Methods: Under the technical guidance of CAREC and CDC, the Ministry organized a technical working group
which included representatives from key national HIV program services and technical assistance partners. This
working group reviewed internationally-recognized best practices for HIV rapid testing and proposed a program
that could be integrated into the national HIV programs of Trinidad and Tobago. The working group wrote a
consensus protocol, defined certification criteria, prepared training materials and oversaw implementation of “same-
visit” HIV testing at two pilot sites.
Results: A Ministry-of-Health-supported program of “same-visit” HIV testing has been established in Trinidad and
Tobago. This program provides confidential testing that is independent of laboratory confirmation. The program
allows clients who want to know their HIV status to obtain this information during a single-visit to a testing
location. Testers who are certified to provide testing on behalf of the Ministry are also counselors. Non-laboratory
personnel have been trained to provide HIV testing in non-laboratory locations. The program includes procedures
to assure uniform quality of testing across multiple testing sites. Several procedural and training documents were
developed during implementation of this program. This report contains links to those documents.
Conclusions: The Ministry of Health has implemented a program of “same-visit” HIV testing in Trinidad and
Tobago. This program provides clients confidential HIV test reports during a single visit to a testing location. The
program is staffed by non-laboratory personnel who are trained to provide both testing and counseling in
decentralized (non-laboratory) settings. This approach may serve as a model for other small countries.
Background
Overview of HIV Testing
Technology for testing
In 1981, the index case for what is now known as
Acquired Immuno-deficiency Syndrome (AIDS) was
reported [1]. Within a few years, the Human Immuno-
deficiency Virus (HIV) had been identified as the infec-
tious agent that causes AIDS [2]. The laboratory work
that led to the identification of HIV as the infectious
agent of AIDS also provided a foundation for develop-
ment of HIV testing. By the mid-1980s, laboratory tests
which could detect HIV antibody had been developed [2].
During the 1990s, HIV testing technology exploded.
This technology explosion included an array of HIV
rapid test devices. Rapid tests are instrument-free assays
designed to detect both HIV antibody and HIV-asso-
ciated antigen. Many of these devices have sensitivities
and specificities comparable to those of laboratory-based
tests and provide the technical basis for decentralization
of HIV testing into non-laboratory locations. Test
decentralization provides policy-makers with opportu-
nities to expand HIV testing into non-laboratory set-
tings. As with many opportunities, these were more
complex than originally imagined.
Policy for testing
In 2001, the United Nations General Assembly Special
Session (UNGASS) on HIV/AIDS asked each of the 189 * Correspondence: cynthiakwarner@mac.com
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responses to the HIV/AIDS epidemic. In response to
UNGASS, many countries prepared National Strategic
Plans (NSPs) outlining country-specific activities for
delivery of HIV/AIDS services. In many places, these
NSPs became tools for improvement of existing HIV/
AIDS services and introduction of new ones.
During 2001, in the wake of UNGASS, many countries
committed to public-health delivery of anti-retroviral
therapy (ART) services and some countries adopted the
goal of Universal Access to ART. In this context, scale-
up of HIV testing services became pivotal. In addition,
in December 2003, the World Health Organization
(WHO) announced the 3 by 5 Initiative [3] in which
three million people would have access to ART services
by December 2005. In this Initiative, HIV testing was
described as the “entry point” to all other HIV services,
including ART. This Initiative focused increased atten-
tion on plans and policies to expand and decentralize
HIV testing.
By 2003, both growing availability and acceptance of
HIV rapid testing technology and increasing availability
of drugs for ART encouraged policy-maker interest in
point-of-service HIV testing. Ideally, HIV rapid testing
would be used to allow individuals who wanted to know
their HIV status to obtain that information during a sin-
gle-visit (or the “same-visit”) to a testing location.
Reports indicate that clients who receive HIV status
reports during the “same-visit” to an HIV testing loca-
tion are much more likely to obtain their test results
than those who must return for a “second-visit” days or
weeks later to receive results obtained after laboratory-
based testing. “Same-visit” HIV-testing also increases cli-
ent confidence in, and acceptance of, HIV testing [4].
Rapid HIV test technology could have significant
impact on control of the HIV/AIDS epidemic. When
HIV testing is more accessible, more people learn their
HIV-infection status. When the “entry point” to ART is
readily accessible, those eligible for ART experience
fewer obstacles to service delivery. Policy advisors face
significant challenges in addressing questions about HIV
testing policy. Integrating the most appropriate technical
options for HIV testing into effective government poli-
cies for prevention, care and treatment of HIV/AIDS
has proven complex [5].
Policy development
Policies concerning scale-up of HIV testing based on
HIV rapid test technology must address several ques-
tions:
1. Which rapid tests will be used?
2. What algorithm will be used to determine the
HIV status of a client?
3. Who will provide testing?
4. How will testers be trained?
5. Will testing always include counseling?
6. Will testers and counselors be the same person?
7 .H o ww i l lq u a l i t ya s s u r a n c eb ei n t e g r a t e di n t ot h e
testing process?
8. Will HIV test results be incorporated into national
HIV/AIDS surveillance reports?
None of these questions has either a single or a simple
answer. Different policy makers have taken different
approaches on each of them. Both international and
regional guidance on these questions is limited. Thus
far, individual countries intending to introduce HIV
rapid testing have had to consider these questions inde-
pendently. Obtaining evidence-based responses for
design of national testing policies has been difficult.
Consensus responses to difficult questions like those
listed above provide the foundation for effective policy.
Effective policy addressingH I Vr a p i dt e s t i n gb e n e f i t s
many programs. In countries with effective policies,
non-governmental organizations (NGOs) can provide
HIV rapid testing in accordance with national policy.
National policy for HIV testing requires input from
many stakeholders. This report summarizes experiences
from one country, Trinidad and Tobago (TT) with
implementation of effective national policy for HIV test-
ing using rapid test technology. Before describing the
policy development process in TT, a review of HIV test-
ing there is appropriate.
HIV/AIDS in Trinidad & Tobago
Trinidad and Tobago (TT) is a twin-island Caribbean
nation at the southern-most end of the Lesser Antilles.
The population of TT is approximately 1.3 million. The
first cases of AIDS in TT were reported in 1983 [6].
UNAIDS characterizes the HIV/AIDS epidemic in TT
as having a prevalence of 2.6%, primarily transmitted by
heterosexual intercourse, and generalized [7]. These
numbers indicate that perhaps 30,000 people in TT are
sero-positive for HIV infection. At the end of 2007,
approximately 4000 patients were receiving ART ser-
vices provided by the MOH.
HIV testing in TT
Laboratory-based testing for HIV infection has been
available in TT since the 1980s. Although this testing
was used primarily for diagnostic purposes, it was not
routinely provided. This situation changed in the mid-
1990s with the introduction of the Prevention-of-
Mother-To-Child-Transmission (PMTCT) Program.
This program included HIV testing for all women who
attended public ante-natal clinics. When the PMTCT
program began, all HIV testing in TT was laboratory
based. The diagnostic algorithm for HIV infection in TT
was complex and women who provided samples for
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results. Many women who were tested never obtained
their test results.
Dependence on laboratory-based HIV testing pre-
sented serious challengest ot h eP M T C Tp r o g r a m .
Timely receipt of results was essential to maximize the
public health impact of the program. The Ministry
wanted to make programmatic and policy transitions
that would liberate HIV testing from the laboratory and
institute “same-visit”,o rp o i n t - o f - s e r v i c e ,H I Vt e s t i n g
within PMTCT clinics. Policy advisors recognized that
well-designed, point-of-service HIV testing would bene-
fit other Ministry programs, especially those involving
ART.
HIV policy in TT
Early in 2004, TT established a National AIDS Coordi-
nation Committee (NACC). The primary tasks of this
committee were to coordinate and monitor implementa-
tion of the NSP for HIV/AIDS. One of the NSP priori-
ties for TT was to expand access to HIV testing. This
priority was assigned to the Ministry. The Ministry pol-
icy advisors understood that this priority would best be
accomplished by transition from HIV testing that
required laboratory confirmation to testing that was
independent of laboratory confirmation.
Like many other countries, TT has a shortage of
trained laboratory personnel. In contrast to many other
countries, TT had many counselors who had already
been trained in HIV counseling. Thus, in TT, optimal
transition from laboratory-based testing would be
achieved by training counselors to provide “same-visit”
HIV testing. In this situation, one person would serve as
both counselor and tester to individuals who requested
HIV testing. This approach facilitates decentralization of
HIV testing and has been described as both “same-visit”
HIV testing and “in-room” HIV testing [4].
In 2004, limited international and regional guidance
was available for “same-visit” HIV testing. In September
2004, the Chief Medical Officer of TT requested techni-
cal assistance from CAREC with implementation of
“same-visit” HIV testing. CAREC is an international
organization administered on behalf of 21 CAREC
Member Countries. In September 2004, CAREC was a
technical partner of the Global AIDS Program (GAP) at
CDC. From October 2003 until December 2005, a
laboratory advisor was assigned by CDC to the GAP
office in Trinidad to provide technical assistance to
CAREC.
CAREC, in partnership with CDC, and in consultation
with local expertise within both the Ministry and the
private sector, developed an implementation protocol.
This protocol was accepted and ratified by the Ministry
and now provides policy for further scale-up of HIV
testing in TT. The remainder of this report describes
this process as it unfolded in TT between September
2004 and mid-2007. This report contains links to the
documents developed in that process.
Methods
Planning process
Implementation of “same-visit” HIV testing in TT was
lead by a multidisciplinary technical working group
(TWG). The TWG had representation from each
administrative entity that would be involved with imple-
mentation of “same-visit” HIV testing. Thus the TWG
included a broad array of professional expertise: physi-
cians, nurses, laboratory personnel, program managers,
counselors and social workers. The TWG also included
individuals who provided technical assistance on behalf
of both CAREC and CDC/GAP. The TWG diversity
incorporated contrasting experiences and expectations
about HIV testing. Over time, TWG diversity matured
into strength of consensus.
Role of the TWG
The TWG reviewed and identified international best
practices for “same visit” HIV testing. These best prac-
tices were incorporated into a protocol (Additional file
1), or technical framework, that specified details for
implementation of “same-visit” HIV testing in TT. In
addition to the protocol, the TWG drafted several other
documents including class-room training materials
(Additional file 2), a Reference Manual (Additional file
3) for testers, certification criteria (Additional file 4),
and a job description for the Ministry post of Quality
Monitor.
Challenges
The most formidable challenges in protocol design were
contained in the terms “quality” and “same-visit” HIV
testing. The Ministry request was for technical assis-
tance with a testing program in which one person, who
served as both counselor and tester, could report quality
test results that were independent of laboratory confir-
mation. One of the program goals was to allow non-
laboratory personnel to report test results from non-
laboratory locations. By requesting technical assistance
in this way, the Ministry maximized the potential impact
of the testing program. The protocol provided a techni-
cal framework by which this program goal could be
achieved.
MOH protocol
The TWG reviewed evidence for the Ministry protocol
from four sources. The first source was Guyana, another
small country in the region. In 2004, Guyana introduced
a national program for HIV testing that had many simi-
larities to the program envisioned by Ministry policy
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shared their lessons learned with both CAREC and
CDC/GAP. The second source was Brazil; in 2004, Bra-
zil was mid-way in plans to implement national policy
for HIV testing. The Brazilian lessons learned provided
information from a much larger country in the region.
Some of these lessons have since been published [8].
Experiences and data from both of these countries were
used to inform TWG decisions. The third source of
information was the PMTCT program in TT. This pro-
gram had begun collecting data about the performance
of HIV rapid tests in TT in 1999; these data were espe-
cially useful to the TWG. The fourth source included
reference documents and recommendations from both
WHO and CDC and other published materials. All
sources are referenced in the Ministry protocol (Addi-
tional file 1).
In addition to referencing source materials, the Minis-
try protocol also provided detailed information on sev-
eral technical topics including: 1) a description of
routine testing integrated into a quality monitoring sys-
tem, 2) the rational for “same-visit” HIV testing, 3) the
evidence for the Ministry algorithm selection and 4) gui-
dance for operation of the pilot and 5) guidance for
expansion to additional sites.
The Ministry protocol also outlines three concepts
that facilitated implementation of “same-visit” testing: 1)
people who provide testing must be certified, 2) sites
which provide testing must be certified; and 3) a Quality
Monitor must provide regular oversight of the testing
process.
Key Feature
The most important feature of the protocol is the
description of new relationships between laboratories
and testers who provide HIV testing on behalf of the
Ministry. The biggest challenge faced by the TWG was
contained in question 7 above: How will quality assur-
ance be integrated into the testing process? The Minis-
try wanted clients who sought HIV testing at “same-
visit” venues to obtain results comparable in quality and
reliability to those they would obtain in laboratory-based
venues. The protocol describes how this can be
accomplished.
Certification Process
The essential components of Ministry-certified testing
are twofold: site-certification and tester-certification.
Site-certification is facility-oriented. The site-readiness
checklist (Additional file 5) identifies items that must be
ready before testing can begin. Tester-certification is a
three-step training program (Additional file 6). Both
site- and tester-certification are subject to annual review.
The Ministry reserves the right to stop testing in any
situation where certification criteria are not met.
Training Program
The protocol stipulates that only testers who are certi-
fied may provide “same-visit” HIV testing on behalf of
the Ministry. The TWG devoted considerable attention
to creating a training program for tester certification.
The classroom materials used in the training program
were customized from the HIV Rapid Testing Training
Package [9]. The Ministry-customized version of the
classroom training materials can be found in Additional
file 2. The laboratory training materials were developed
b yt w oo ft h ea u t h o r so ft h i sd o c u m e n t( C Aa n dC W )
and outlines for these materials are in Additional file 7.
Full certification for Ministry testers is a three-step
process (Additional file 6). Each person who is certified
to provide testing must complete a training workshop, a
laboratory internship and a proficiency exam.
The training workshop is a 3-day event that includes
both classroom time (14 hours) and hands-on training
(10 hours). During classroom time, workshop partici-
pants listen to lectures, participate in group discussions
and use teaching aids to increase their interpretative
skills. Skill with interpretation of HIV-status according
to national testing algorithm is integral to the quality
system for “same-visit” HIV testing. In addition, trainees
must learn to interpret results from testing quality-con-
trol (QC) materials.
During hands-on training, workshop participants were
encouraged “to think like lab people”. During this train-
ing, the ratio of trainees to facilitators was 4:1. Facilita-
tors observed and interacted individually with trainees
as they learned the details of testing. Testers must
acquire skills that are routine for laboratory staff. During
the practical sessions, workshop participants learned to
use transfer pipettes, to perform finger-stick blood col-
lection, to use rapid-test devices, to keep accurate
records, to conduct routine testing of QC materials and
to use the Ministry national algorithm to provide HIV
infection status reports.
To integrate quality into “same-visit” HIV testing, each
component of training was customized to the Ministry
national testing algorithm. The training included use of
standard operating procedures (SOPs) for each step of
the testing process. All hands-on practical time was
SOP-driven. Each workshop participant was given a
Reference Manual (Additional file 3) containing all
SOPs.
Training workshops included both written and practi-
cal examinations. To successfully complete a training
workshop, participants were required to score 80% on a
written exam and 100% on a practical exam. Sample test
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tional file 8.
After successfully completing a training workshop,
certification-candidates enrolled in a laboratory intern-
ship. During the internship, each candidate tested 50
known samples under supervision of a certified tester. A
member of the clinical laboratory staff at Port of Spain
General Hospital served as supervisor for laboratory
interns.
After successfully completing an internship, certifica-
tion-candidates were required to complete a proficiency
exam. The proficiency exam involved accurately testing
a panel of unknowns. The unknowns were purchased
from an external supplier. Additional information about
the panels used for Ministry certification can be found
in Additional file 1.
Samples for Testing
Finger-stick blood draw is used for sample collection for
“same-visit” HIV testing in TT. This method provides
suitable samples for client testing and significantly
reduces biological risk hazards at testing sites.
Quality Assurance
The Ministry protocol specifies daily testing of quality
control (QC) materials by each person who provides
testing. Each tester must test both known positive and
negative QC samples with each of the tests in the Min-
istry algorithm on each day of testing. This means that
daily QC testing requires 6 tests per tester per site and
the total daily cost of testing must include costs of these
supplies.
Regular testing of QC materials is the most important
feature of the quality program described in the Ministry
protocol. Results from testing of QC materials must be
available each day before testing can begin. If there are
problems with the daily QC testing, “same-visit” HIV
testing must be halted until the problems are resolved.
In addition, these QC test results are regularly reviewed
by the Quality Monitor as part of each site audit. These
QC test results are essential to trouble shooting pro-
blems that arise with decentralized testing. In short, QC
sample results are integral to allowing HIV testing to be
independent of laboratory confirmation.
Pilot Site Testing
T h eM i n i s t r ys e l e c t e dan e w l yr e f u r b i s h e dp u b l i ch e a l t h
sector clinic in Port of Spain as the pilot site for “same-
visit” HIV testing. Differences existed between what the
TWG had discussed as suitable space for HIV testing
and what was found at the pilot site. These differences
led to the development of a site-readiness checklist
(Additional file 5). The manager of the pilot site and
others from the TWG oversaw renovations at this site.
When the site fulfilled the readiness criteria, it was
designated as the pilot site for “same-visit” HIV testing.
After the “same-visit” HIV testing was optimized at
the public health sector pilot site, it was expanded to a
second site. The second site was an NGO contracted by
the Ministry to provide reproductive health services at
five locations in TT. The site selected for expansion of
testing had facilities that met site-certification criteria
and three staff members who had completed Ministry
tester-certification. CAREC recommended that this
NGO location add “same-visit” HIV testing to its pro-
gram services. CAREC funded and provided technical
oversight to this NGO. CAREC also advocated for
national policy that would include NGO provision of
“same-visit” HIV testing.
Results
Consensus process
Protocol consensus facilitated transition to “same-visit”
HIV testing in TT. The professional diversity of the
TWG meant that consensus for the protocol developed
slowly. By creating a diverse TWG to guide this process,
the Ministry obtained a protocol for HIV testing that is
independent of laboratory confirmation. This became
the policy tool that made “same-visit” testing a reality.
Policy adoption
The TWG protocol was completed in December 2005.
The protocol was reviewed at CAREC and in January
2006, the Ministry ratified the protocol and adopted it
as policy for HIV testing in TT. This Ministry policy
facilitated additional piloting of “same-visit” HIV testing
in the public-health-sector-clinic pilot site and allowed
expansion to the NGO-sponsored-clinic site. During the
first year after policy adoption, more than 2500 clients
received “same-visit” HIV test results.
Pilot testing
A pre-pilot stage of testing began in July 2005. The pub-
lic health clinic selected as the pilot location had two
rooms and three clinic staff members which met Minis-
try-certification criteria. During July 2005, 22 clients
received test results at this site. Members of the TWG
and other consultants visited the site often to monitor
the initial weeks of testing. These visits provided oppor-
tunities for testers to discuss problems and find solu-
tions. Testing expanded slowly and by the end of 2006,
2323 clients had received test results at this site; for an
average of 185 clients per month. By June 2007, 83 cli-
ents at this location had been diagnosed HIV-positive
and referred to an ART location. Testing at this site is
provided to clients free of charge. This site is included
in the Ministry medical warehouse supply system and
all testing supplies at this site are obtained through this
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who tested HIV-positive at this site will be presented in
a subsequent publication.
In May 2006, “same-visit” HIV testing was expanded
to a second site, an NGO clinic near the pilot site. Test-
ing at this site began with three certified testers and one
certified testing room. This site is not part of the Minis-
try public health sector and maintains an independent
inventory supply chain. Because this site could not pro-
cure testing supplies through the Ministry medical ware-
house system, CAREC agreed to support the initial costs
of HIV test kits. This site opted to provide testing on a
“cost-recovery” basis. Uptake of testing at this site has
been significantly less than at the public health clinic
location. During the first month 15 people were tested.
By June 2007, more than 400 clients had been tested at
this site. Five were diagnosed HIV-positive and referred
to a nearby ART location.
Use of third test
The Ministry protocol stipulated that the third test in
t h ea l g o r i t h mw o u l do n l yb eu s e df o rc l i e n tt e s t i n g
when discordant results were obtained with the first two
tests. By January 2007, more than 2500 clients had
obtained HIV test results. Two of those clients had dis-
cordant results in the first two tests of the algorithm.
Both of these clients tested negative with the third test
in the algorithm. Both clients received negative HIV sta-
tus reports. To date the primary use of the third HIV
rapid test is as one part of the QC material testing
process.
QC Results
As indicated previously, the approach used to monitor
quality of testing in the TT program had not been used
elsewhere. Limited international guidance was available
to the TWG on this topic. The TWG recommended
each tester should test one positive and one negative
QC sample with each rapid test on each day of testing.
The QC sample results compiled at the pilot site and
the NGO site between July 2005 and April 2007 are
shown in Table 1. By June 2007, more than 3800 indivi-
dual QC samples had been tested. These represent more
than 900 “tester days” of HIV testing. The samples were
tested using more than 10 different lot numbers of
rapid tests by 5 different testers. None of the individual
QC sample tests gave invalid or incorrect results. (QC
samples were not tested with Stat-Pak for several
months and these data are not available.)
Cost of testing
Review of the cost of “same-visit” HIV testing in accor-
dance with the Ministry policy is instructive. A price list
of the supplies needed for testing is included (Additional
file 9. All supplies used at the health-clinic pilot site and
for tester certification training were obtained through
the Ministry medical warehouse system. All price nego-
tiations were internal to that system. The Ministry pro-
tocol specifies daily use of QC materials by each person
who provides testing. This means that daily QC testing
requires 6 tests per tester and the total daily cost of test-
ing supplies must include costs of these supplies. During
2006, the daily cost of testing QC materials was TT
$106.06 (or US$17.67). Test supplies for the two tests
for client testing cost TT$31.79 (or US$5.30).
The daily cost of testing per client varies according to
the number of clients tested. The number of clients
tested by each tester during a single day can vary from
1 to 10. When only one client is tested during a day,
the total cost of supplies must include both the QC sup-
ply testing cost (TT$106.06) and the client supply test-
ing cost (TT$31.79) for a total of TT$137.79 (or US
$22.96). When 10 clients are tested in a day, the total
cost of supplies (TT$106.06 for QC supplies and TT
$317.90 for client supplies) is TT$423.96 (US$70.66).
This cost can be averaged over 10 clients reducing the
cost per client to TT$42.40 (US$6.73). (One US$ has a
value of approximately six TT$.)
A final aspect of testing cost is the cost of training
supplies needed to train testers. Under the Ministry pro-
tocol, testers seeking full-certification to provide “same-
visit” HIV testing are required to test 50 samples under
supervision of a certified tester. In TT, these supplies
were also obtained through the Ministry warehouse sys-
tem. During 2006, the price of training supplies for each
candidate cost was TT$6,353.00 (or US$1,065.00).
Conclusions
Policy process
The process of developing a national policy for “same-
visit” HIV in TT was challenging. In September 2004,
when the Ministry requested technical assistance from
Table 1 Summary of QC sample data.
QC positive samples
tested
QC negative samples
tested
Total
Pilot Site
Determine 638 638 1276
UniGold* 635 635 1270
Stat-Pak** 348 348 696
NGO site
Determine 95 95 190
UniGold 95 95 190
Stat-Pak 95 95 190
Total 1906 1906 3812
*Three sets of UniGold QC results were missing from the data log.
**QC results for Stat-Pak were not collected at the pilot site for an extended
period in mid-2005.
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ested in introducing similar testing. At that time, only
one Caribbean country, Guyana, had Ministry of Health
policy for HIV testing based on rapid test technology.
Several different programs within the Ministry in TT
were interested in implementing “same-visit” HIV test-
ing. The Ministry had the wisdom to designate a TWG
that represented these diverse program interests. This
TGW diversity was an enormous challenge at the outset
of protocol development. Forging diversity into an evi-
dence-based, consensus protocol took many months.
The Ministry policy satisfies multiple interests and con-
cerns within the health sector of the country.
Quality Monitoring
The challenges inherent in quality monitoring of “same-
visit” HIV testing should not be under estimated. Pro-
grams that involve HIV testing by non-laboratory staff in
non-laboratory settings provide unique challenges to qual-
ity monitoring. Because rapid test devices are single use
devices, the traditional approaches used to monitor quality
of laboratory-based testing are not directly applicable.
Guidelines for quality monitoring of HIV testing have
been prepared [10]. These guidelines have been used in
high-volume settings where veni-puncture blood is used
for testing. These guidelines are less useful in low-
volume settings where finger-stick blood is tested. The
quality monitoring approach described in these guide-
lines is known as re-sampling. The re-sampling proce-
dure uses dried-blood-spots (DBS). This quality-
monitoring approach, DBS re-sampling, is incompatible
with finger-stick blood collection. Dried blood spots
require approximately 100 microliters of blood per spot.
Re-sampling procedures usually specify 3 spots for test-
ing. Thus DBS resampling requires 300 microliters of
blood. Blood volumes collected by finger-stick collection
vary significantly, but on average 200 microliters or less
can be collected from one finger-stick procedure.
Finger-stick blood collection
The TWG recommended use of finger-stick blood col-
lection for HIV testing in TT. This method of blood
collection provides suitable samples for client testing
and streamlines the testing process. This choice had sev-
eral advantages. The two or three drops of blood
obtained by finger-stick collection are sufficient to com-
plete testing according to the Ministry protocol. Person-
nel and supplies for phlebotomy are not needed. No
“extra” blood is collected, and thus there are no risks of
accidental spills, sample mix-up or mislabeling.
An important corollary of finger-stick blood collection
is that no samples are available for laboratory-based
confirmation. The approach to quality monitoring must
be designed accordingly. Over a period of several
months the TWG developed consensus for quality mon-
itoring with the following words: “At the beginning of
each day of HIV rapid testing, each staff member who
will provide test results must test two externally-pro-
vided QC samples (one HIV-positive sample and one
HIV-negative sample) using each type of HIV rapid
test.” (Encouragement to pursue this approach was pro-
vided by David Barnett in November 2004; CW personal
communication).
The TWG recognized that this approach to quality
monitoring would increase the cost of testing. The cost
of this process per test would be averaged over the total
number of clients tested each day. This number was
predicted to vary between one and ten. In their consen-
sus decision, the TWG agreed that concerns about
maintaining quality testing took precedence over con-
cerns about the cost of testing. Their protocol decision
meant that results from 6 rapid tests would be part of
the quality system for each tester on each day of testing.
The results are kept in the QC sample log which is one
of the most important records of the quality monitoring
system (see Additional file 1).
Limitations
One limitation for “same-visit” HIV testing in TT is asso-
ciated with maintenance of QC sample log records. QC
sample log records can be maintained either on paper or
electronically. Electronic records are much easier to
review. The review of paper records is tedious. Review of
these records is one of the “rate-limiting” steps in further
expansion of “same-visit” HIV testing in TT.
A second limitation of this approach is that it is labor
intensive. Although this approach uses non-laboratory
personnel to provide testing, the people who provide
testing must be trained. When personnel turn-over is
high, training expenses can become a significant compo-
nent of overall costs.
Summary
In 2006, Trinidad and Tobago adopted National Policy
for “same-visit” HIV testing. This policy incorporated
international best practices into a program of Ministry-
certified HIV testing. In this program, one person serves
as both counselor and tester to individuals who seek
confidential HIV status reports. Finger-stick blood sam-
ples are tested in a parallel algorithm and clients receive
test results within 30 minutes. The quality monitoring
aspects of this testing program can be used in non-
laboratory settings and are suitable to monitor testing
across multiple testing sites. The program is staffed by
non-laboratory personnel who are Ministry-certified to
provide quality testing in decentralized (non-laboratory)
settings. This approach is working well in TT and may
serve as a model for other venues.
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Page 7 of 8Additional file 1: Protocol for implementation of diagnostic HIV
rapid (same-visit) testing: Trinidad and Tobago. This document is the
technical framework (protocol) adopted by the Ministry for
implementation of “same-visit” HIV testing.
Additional file 2: Classroom training materials. This document
includes the classroom-training materials used to train non-laboratory
personnel to use rapid tests to provide “same-visit” HIV test results.
Additional file 3: Reference Manual. This is the Reference Manual
provided to each person trained to provide rapid tests to provide “same-
visit” HIV test results.
Additional file 4: Certification Criteria. This document lists certification
criteria and supplies for both testers and venues that provide “same-visit”
HIV test results.
Additional file 5: Check List: HIV Testing Site. This document lists
items that must be ready on-site before testing can begin.
Additional file 6: Tester certification training program.T h i s
document provides an overview of the three-step training program
required for tester certification.
Additional file 7: Hands-on training materials. This document
describes the hands-on portion of training for tester-certification.
Additional file 8: Sample questions. This document lists sample test
questions used to prepare exams required for tester certification. The
question list was submitted to a web-based program which generated a
random selection of test questions for each exam. Each exam included
25 questions. No two exams were identical.
Additional file 9: Cost of testing. This document presents costs
associated with “same-visit” HIV testing.
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